The dilemma of myomectomy, morcellation, and the demand for reliable metrics on surgical quality
Menée aux Etats-Unis à partir de données portant sur 41 777 femmes ayant subi une myomectomie, avec ou sans morcellation électrique de l'utérus, cette étude analyse la prévalence d'anomalies précancéreuses et de cancers associés à cette opération chirurgicale
In late 2013, a public awareness campaign was initiated after electromechanical morcellation (EMM) of a uterus with presumed benign leiomyoma, which in fact was leiomyosarcoma (LMS). Over the past year, the focus of the medical community has been on the incidence of occult LMS, specifically related to EMM. The risk of intracorporeal tissue dissemination by EMM resulted in some manufacturers halting sales of the EMM device, various hospitals banning the procedure, and ultimately a black box warning from the US Food and Drug Administration (FDA) for electromechanical morcellators.1
JAMA Oncology , commentaire, 2014